.Psychopharmacology has pulled three write-ups about midstage medical trial data examining Lykos The...
.Avidity Biosciences impressed investors with phase 1/2 information in Duchenne muscle dystrophy (DM...
.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a phase 2 research in cl...
.Antibody-drug conjugates (ADCs) have actually gone to the facility of many a billion-dollar biobuck...
.Resource manager TPG, which has actually assisted biotechs such as Sionna Rehabs and Santa Clam Ana...
.Merck & Co.'s TIGIT system has actually suffered another trouble. Months after shuttering a phas...
.After a year determined by pipe hairstyles, the departure of its own CEO as well as unemployments, ...
.Cullinan Rehab was impressed good enough with Harbour BioMed's bispecific immune activator that it ...
.In this particular week's incident of "The Leading Line," our team're diving into Tough Biotech's a...
.The confetti is actually still flying coming from Eli Lilly's gathering celebrating the approval of...